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Abstract 
Diabetic Ketoacidosis is a life-threatening side effect to Diabetes Mellitus.  Standards of 
treatment and recommendations are made by the American Diabetes Association.  The project 
was to evaluate and provide the latest evidence-based practice to update the hospital policy for 
the treatment of DKA in the Intensive Care Unit and Emergency Department.  Retrospective 
chart reviews were conducted to review the number of patients admitted with diabetic 
ketoacidosis and treated on the DKA Insulin Infusion Protocol before and after the update.  
Rapid correction of blood glucose levels proved to be an issue at this facility both before and 
after the updates were made to the DKA Insulin Infusion Protocol.  The data supports the need 
for change in protocol, staff development in the use of the protocol and the need for change in 
the emergency department as well as the intensive care unit.  
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glucose monitoring 
 
 
 
 
 
 
 
 
 
SCHOLARLY PROJECT 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
©2018 
Susan K. Lacey 
ALL RIGHTS RESERVED 
SCHOLARLY PROJECT 5 
Acknowledgements 
 
 First and foremost, I want to thank my family. Without them I could not have taken on 
this journey to obtain the Doctor of Nursing Practice.  I would also like to thank my fellow 
classmates, especially Kathryn Wampole and the faculty of Liberty University that have 
provided support and encouragement through this process.  
I want to thank my husband who has been my biggest supporter through my nursing 
school journey.  Thank you for always believing that I could do this.  To my daughter, thank you 
for reminding me why I am furthering my education and telling me to never give up.   
 To my chair, Shanna Akers, EdD, MSN/MBA-HC, RN, CNE, thank you for supporting 
me through this scholarly project and providing the guidance I needed to succeed.  You were a 
beacon of hope when I was ready to give up. 
To all the members of the interdisciplinary team, Chief Nursing Officer, Ms. Sharon 
Marti, MBA, MSN, CPPS, the Physician Informaticist, Dr. Jeffery Abrams, M. D., FACP, the 
Director of Acute Care Services, Debra Douglas, MSN, RN, the Director of Quality and Safety, 
Ms. Pauline Roush, MSN, RN, the Director of Pharmacy, Dr. Gary Matthews, and the Clinical 
Coordinator/Educator Intensive Care Unit, Monica Crivaro, BSN, RN.  All other personnel 
involved including the nursing education department and the staff for both the ICU and ED.  A 
special thank you goes to Dr. Steven Sinnott for assisting with all of the statistical data analysis. 
Thank you Andrew Martineau and Norma Smith for editing this scholarly project.  
 Finally, to my preceptors, Debra Douglas and Pauline Roush, you have both supported 
me through this process, and I am eternally grateful.  I have learned so much from both of you 
from your knowledge and experience.  I would also like to acknowledge the members of my 
interdisciplinary team and the staff for helping me to achieve my goals.  
SCHOLARLY PROJECT 6 
Table of Contents 
List of Tables .................................................................................................................................. 7 
List of Abbreviations ...................................................................................................................... 8 
SECTION ONE: INTRODUCTION........................................................................................... 9 
Problem Statement ................................................................................................................................ 10 
Purpose of the Project .......................................................................................................................... 10 
Clinical Question ................................................................................................................................... 10 
SECTION TWO: LITERATURE REVIEW ........................................................................... 11 
Search Strategy ..................................................................................................................................... 11 
Review of Literature ............................................................................................................................. 11 
Conceptual Framework ........................................................................................................................ 14 
Theoretical Framework ........................................................................................................................ 15 
SECTION THREE: METHODOLOGY .................................................................................. 15 
Design ..................................................................................................................................................... 15 
Measurable Outcomes .......................................................................................................................... 16 
Setting .................................................................................................................................................... 16 
Population .............................................................................................................................................. 16 
Ethical Considerations .......................................................................................................................... 17 
Data Collection ...................................................................................................................................... 17 
Tools ....................................................................................................................................................... 18 
Data Analysis ......................................................................................................................................... 18 
Statistical Analysis ................................................................................................................................ 19 
Feasibility Analysis ............................................................................................................................... 26 
Resources ............................................................................................................................................... 26 
Personnel ................................................................................................................................................ 26 
Technology ............................................................................................................................................. 27 
Significance and/or Implications ......................................................................................................... 27 
Evaluation and Dissemination ............................................................................................................. 27 
Recommendations ................................................................................................................................. 28 
References ..................................................................................................................................... 30 
Appendix ....................................................................................................................................... 34 
 
 
  
SCHOLARLY PROJECT 7 
List of Tables 
Table 1: Pre-data Patient #3……………………….………………………………………….…20 
Table 2: Pre-data Patient #5……………………………………………………………………..20 
Table 3: Pre-data Patient #8……………………………………………………………………..21 
Table 4: Pre-data Patient #11..…………………………………………………………………..21 
Table 5: Pre-data Patient #14..…………………………………………………………………..22 
Table 6: All Pre-data compiled.………………………………………………………………....22 
Table 7: Post-data Patient #4…………………………………………………………………....23 
Table 8: Post-data Patient #5…………………………………………………………………....24 
Table 9: Post-data Patient #7……………………………………………………………………24 
Table 10: Post-data compiled…………………………………………………………………...25 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SCHOLARLY PROJECT 8 
List of Abbreviations 
 
American Diabetes Association (ADA) 
Collaborative Institute Training Initiative (CITI) 
Critical Care Pathway (CCP) 
Diabetic Ketoacidosis (DKA) 
Dissemination, Implementation and Improvement (DII) 
Doctor of Nursing Practice (DNP) 
Electronic Health Record (EHR) 
Emergency Department (ED) 
Health Insurance Portability and Accountability Act (HIPAA) 
Institutional Review Board (IRB) 
Intensive Care Unit (ICU) 
Length of Stay (LOS) 
Randomized Controlled Trial (RCT) 
 
 
 
 
 
 
 
SCHOLARLY PROJECT 9 
SECTION ONE: INTRODUCTION 
 
Diabetic Ketoacidosis (DKA) can be a life-threatening emergency in both the diagnosed 
and undiagnosed patients with diabetes.  The American Diabetes Association (ADA) makes 
recommendations on the treatment of diabetes mellitus as well as treatment of DKA.  The ADA 
has established protocols and algorithms for the treatment of DKA.   
The site of this project is Fauquier Health, which is a Life Point Hospital, located in 
Northern Virginia (Fauquier Health, 2018).  Fauquier Health treats adult patients with DKA in 
the emergency department (ED) and intensive care unit (ICU) using an Insulin Infusion Protocol.  
This protocol was developed in 2014 and needs updates based on the latest recommendations by 
the ADA, as well as evidence-based research on the subject.  Fauquier Health’s mission is to 
make the community healthier (Fauquier Health, 2018).  Their vision is to create places where 
people choose to receive healthcare and where both physicians and employees want to work 
(Fauquier Health, 2018).  Additionally, their values include the delivery of high quality care, 
support of the physicians and employees, fiscal responsibility and leadership in the community 
(Fauquier Health, 2018).   
Members of the department of nursing, emergency department staff and intensive care 
unit staff, as well as the informatics physician, felt there was a need to update the current DKA 
Insulin Infusion Protocol with the latest recommendations by the ADA as well as with evidence-
based practice.  This scholarly project examined the latest research and recommendations for the 
treatment of adult’s age 18-75 who are admitted with DKA and treated with Insulin Infusion 
Protocols. 
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Problem Statement 
At Fauquier Health, when an adult patients are admitted with a diagnosis of DKA, they 
are treated with an outdated Insulin Infusion Protocol.  A possible complication of the use of this 
protocol is rapid correction that can lead to further complications such as signs or symptoms of 
hypoglycemia.  Additionally, the process regarding the measurement of blood glucose by the 
nursing staff in the ICU and respiratory therapy as the policy states was in question.  To reduce 
these possible complications, a review of the protocol and the most recent research was 
examined.   
Purpose of the Project 
The purpose of this scholarly project was to examine the DKA Insulin Infusion Protocol 
being used in the ICU and ED to update the protocol to the most up to date research by the ADA.  
A team of health care professionals which included the Informatics Physician, the Director of 
Pharmacy, the Director of Acute Care Services and the Clinical Coordinator for the ICU 
reviewed the recommendations for updating the protocol and adopted most of the changes.  
Afterwards, staff development courses were developed, a poster project for display in both the 
ICU and ED was presented by the DNP student.  In order to improve adherence to the policy, it 
is important to educate the stakeholders when treating critically ill patients.   
Clinical Question 
The use of the current protocol for adult patients with the DKA insulin infusion at 
Fauquier Health has led to several patients who were rapidly corrected leading to complications 
of hypoglycemia.  Concern was expressed that blood glucose monitoring in the ICU is not being 
followed per the protocol by the nursing staff and respiratory therapy staff.  The protocol needed 
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updating with evidence-based practice.  Can a change of the Insulin Infusion protocol reduce the 
incidence of complications due to rapid correction of blood glucose in the adult DKA patient? 
SECTION TWO: LITERATURE REVIEW 
 
Search Strategy 
A systematic search was conducted for peer-reviewed journals published within the last 
three to five years using the following: CINAHL, EBSCO, Up-to-date and MEDLINE.  This 
search included the following keywords: Insulin Protocol, DKA, Diabetic Ketoacidosis 
treatment, Diabetic emergencies, and glucose monitoring.  The search revealed multiple articles 
and peer reviewed journals on the subject.  Articles were then reviewed and further scrutinized 
for relevance ending with 13 articles for review.  They were evaluated using Melnyk Levels of 
Evidence which revealed two level I, two level II, one level III, two level IV, three level V and 
two level VII (Melnyk & Fineout-Overholt, 2015).  
Review of Literature 
Clain, Ramar, and Surani (2015) reviewed 11 major randomized controlled trials (RCT) 
which investigated the use of intensive insulin therapy and conventional insulin therapy.  After 
reviewing these studies, the authors concluded that the insulin therapies varied greatly, and there 
was no clear evidence to support one over another (Clain, Ramar, & Surani, 2015).  Tran, et al. 
(2017) completed a review of DKA management protocols to examine strengths or weaknesses 
of such protocols.  The authors found major deficiencies among the evidence for optimal 
management of DKA (Tran, et al., 2017).  The deficiencies included a lack of timing of 
initiation, titration of IV fluids and replacement of electrolytes.  They concluded that further 
studies were needed as well as the need to include robust evidence-based practices to improve 
patient outcomes (Tran, et al., 2017). 
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Wilinska and Hovorka (2014) evaluated three established glucose control protocols for 
the treatment of DKA.  The protocols were tested on 56 virtual patients (Wilinska & Hovorka, 
2014).  When the authors compared continuous glucose monitoring and hourly blood glucose 
level monitoring, the three glucose control protocols varied in effectiveness.  The authors 
reviewed management of blood glucose levels in hospitalized patients, which requires a team 
approach, requires education of all multidisciplinary team members, and careful implementation 
and use of standardized protocols (Mackey & Whitaker, 2015).  Patients with diabetes can 
present the health care providers with challenges to keep glycemic control, especially those who 
are critically ill.  Mackey and Whitaker (2015) observed some of these challenges as the 
pharmacodynamics of insulin, types of insulin used and delivery of insulin.  Oral agents would 
not be given to critically ill individuals, which leaves insulin preparations and administration by 
subcutaneous, basil-bolus, bolus insulin and correction therapy (Mackey & Whitaker, 2015).  
Correction insulin therapy can be added to other fluids and can be used intravenously as an 
insulin infusion.  Regardless of the method used, the authors stressed the importance of 
institutional guidelines being used to control blood glucose levels in hospitalized patients 
(Mackey & Whitaker, 2015). 
The creation of an insulin infusion protocol and best practices is the aim of this scholarly 
project.  Clergeau et. al (2017) assessed the efficacy, safety and acceptance of insulin protocols 
in the ICU.  The authors reviewed 131 ICU patients who received continuous intravenous insulin 
infusions (dynamic infusion protocols) or sliding scale insulin for management of DKA.  The 
conclusion included that the dynamic infusion protocols reduced glycemic variability, and 
therefore, the risk of patients experiencing hypoglycemic events (Clergeau et al., 2017).    
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An examination was conducted of the effectiveness of two different insulin infusion 
protocols in a medical intensive care unit using 57 patients (DeBlock et al., 2016).  Twenty-two 
patients were treated with the Leuven protocol, and 35 patients were treated with the Yale 
protocol.  The Leuven protocol uses continuous intravenous insulin with a target blood glucose 
level between 80 and 100 mg/dl (DeBlock, et al., 2016).  The Yale protocol uses intravenous 
insulin and a target blood glucose level between 80 and 120 mg/dl (DeBlock, et al., 2016).  No 
significant differences in the median glycaemia between the two protocols were found (DeBlock 
et al., 2016).   
A retrospective cohort study was conducted, which evaluated the clinical efficacy and 
safety of two types of insulin, human neutral insulin and NovoRapid (insulin aspart) for the 
treatment of DKA.  Forty patients who had been admitted through the emergency department 
with a diagnosis of DKA were reviewed (Kwok et al., 2017).  In this study, the authors found a 
significant difference in the types of insulin preparations used in the treatment of DKA (Kwok et 
al., 2017).  However, no significant statistical difference was found to support the use of one type 
of insulin over the other (Kwok et al., 2017).   
Martin, McKinney, Hoody and Fish (2016) completed a study at a 426-bed hospital to 
review treatment outcomes of critical care pathways.  Critical care pathways (CCP) used in the 
treatment of DKA were reviewed in association of length of stay (LOS) and the authors found a 
decrease in LOS with the use of CCP (Martin, et al., 2016).  Important factors to consider in the 
use of CCP are that it should be mandatory, utilize aggressive IV fluid management and insulin 
administration and address the patient’s electrolyte imbalances (Martin, et al., 2016).   
An executive committee examined randomized control trials, which examined the 
prevalence of diabetes in hospitalized adults (Panikar et al., 2016).  Based on the findings the 
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executive committee developed an in-hospital protocol for recognizing hyperglycemia (Panikar 
et al., 2016).  Using a target glucose of 140-180 mg/dl has been shown to reduce the incidence of 
hypoglycemia in the critically ill patient on insulin infusion protocols (Soo Hoo, 2015).  In the 
study by Soo Hoo (2015), the author concluded that the factors, which greatly influenced patient 
outcomes, were adherence to policies and guideline.   
Transitioning DKA patients from an insulin infusion protocol to subcutaneous insulin can 
be a critical piece in the overall favorable outcome of these patients.  Kreider and Lien (2015) 
completed a literature review on this subject.  The authors examined interventions to safely 
transition patients from intravenous insulin infusions to subcutaneous insulin and found that no 
one protocol worked best for all patients (Krieder & Lien, 2015).   
Other situations exist which affect the outcomes of patients admitted in DKA, such as 
hypoglycemia, metabolic acidosis and electrolyte imbalances.  Brutsaert, Carey and Zonszein 
(2014) examined the incidences of hypoglycemia in hospitalized patients.  The authors 
concluded that there were many gaps in knowledge relating to treatment of hypoglycemia 
(Brutsaert, Carey, & Zonszein, 2014).  A case report was completed on the deterioration of a 
patient in DKA.  Consequently, the finding was similar in that the patient had to be rescued 
instead of the physicians or nurses recognizing the need for correction of metabolic acidosis and 
electrolytes (Van de Vyver, Damen, Haentjens, Ballaux, & Bouts, 2017). 
Conceptual Framework  
The conceptual framework is the IOWA Model, which will be used as a guide for this 
scholarly project.  The IOWA Model is a seven-step process, which starts with selection of a 
topic and works through a process ending with evaluation (Doody & Doody, 2011).  The IOWA 
Model is a systematic process, which begins with the identification of the trigger or opportunity 
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for change (Zaccagnini & White, 2017).  In this scholarly project, the trigger is rapid correction 
of blood glucose in patients admitted to Fauquier Health in DKA resulting in adverse reactions.  
Once the trigger was identified and the clinical question was developed, the author went through 
the steps of the IOWA Model, resulting in the development of evidence, design of a study, 
intervention and finally the dissemination of the project (Zaccagnini & White, 2017).   
Theoretical Framework 
The theoretical framework that will be used for this scholarly project is the Transitional 
Care Model.  This theory was designed for use on patients who are transitioning from a hospital 
setting to home care (Romagnoli, Handler, Ligons, & Hochheiser, 2013).  The patients admitted 
to Fauquier Health will transition from IV Insulin therapy to subcutaneous insulin as well as 
transitioning from intensive care to discharge.  Making this transition can be very difficult in 
populations of patients newly diagnosed with diabetes or patients who are poorly controlled 
diabetics. 
SECTION THREE: METHODOLOGY 
 
Design 
 The design of this scholarly project was a retrospective chart review both 90 days prior to 
implementation and 90 days after.  Baseline data was compiled regarding the number of adult 
patients age 18-75, who were admitted to Fauquier Health in DKA and who were treated with 
the Insulin Infusion Protocol.  Once it was determined that the patient had a diagnosis of DKA 
and they were placed on the Insulin Infusion Protocol, the chart become part of the retrospective 
review.  After adoption of the updated DKA Insulin Protocol, a second retrospective chart review 
was conducted for the first 90 days to compare the data from the first retrospective chart review. 
The charts were examined and reviewed for the amount of time from initiation to correction of 
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blood glucose if rescue medications had to be given and how the patient tolerated the insulin 
infusion.  
Measurable Outcomes 
 The DKA Insulin protocol was updated, which outlines how to manage patients admitted 
with diabetes to the ICU from the ED.  In addition to the DKA Insulin Infusion protocol update, 
an update to the Nursing Guidelines for blood glucose monitoring in the ICU was achieved.  This 
was based on the data collected which showed the difference between a finger stick blood 
glucose level and a random glucose drawn and process in the lab.  The decision was made to 
change the policy to reflect that patients on the DKA Insulin Infusion Protocol should only have 
random glucose levels drawn.   
Adult patients who present in DKA, with new onset or chronic diabetes will be properly 
managed with the DKA Insulin Protocol; the amount of time and level of blood glucose 
correction was monitored which should not exceed 50-70 mg/dl per hour.  Additional health care 
outcomes measured included the mean time of patients admitted in DKA to reach correction of 
electrolyte imbalance and correction of anion gap after the implementation and dissemination of 
this updated DKA Insulin Infusion Protocol. 
Setting 
A for-profit, community hospital in Northern Virginia is the site for this study.  This 
hospital is licensed for 100 beds.  The units monitored included the ICU and ED.   The project 
aligns with the organization’s mission, values and strategic plan by concentrating on patient care. 
Population  
This scholarly project included only adult patients age 18-75, admitted to Fauquier 
Health in DKA and treated in the ICU or ED, 90 days prior to initiation of the updated DKA 
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Insulin Protocol and 90 days afterwards.  However, the month of May was excluded completely 
due to the initiation of the order set changes without the protocol change implementation.  A 
total of 15 charts were reviewed for the retrospective review of the 90 days prior to initiation.  Of 
those 15 charts, three charts were excluded as they were admitted under the correct diagnostic 
code although they were never placed on the DKA Insulin Protocol.  The sample size for the first 
retrospective review was an npre = 11.  A total of seven charts were reviewed for the retrospective 
review of the 90 days post implementation, of those charts all seven met the inclusion criteria 
and were placed on the DKA Insulin Protocol.  The sample size for the second retrospective 
review was an npost = 6. 
Ethical Considerations 
 Ethical considerations for research on human subjects was strictly enforced.  An 
Institutional Review Board (IRB) exemption was obtained from the Liberty University IRB.  A 
letter of support for this scholarly project was obtained from Fauquier Health.  Patient privacy 
was maintained as outlined by the health insurance portability and accountability act (HIPAA).  
All charts reviewed were coded and no patient names or medical record numbers for 
identification were used.  All correspondence between Fauquier Health and this author have been 
sent by encrypted email and the computer is password protected.   
Data Collection 
Information was collected from charts of patients admitted to ICU from the ED who are 
found to be in DKA and were placed on the initial Insulin Infusion Protocol.  Data collection for 
the 90-day retrospective chart review prior to initiation of the protocol included all patients 
admitted in DKA from February 1, 2018 through April 30, 2018.  The data for the month of May 
was excluded due to a change in the order set used for DKA without the accompanying written 
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protocol of the change.  The 90-day retrospective chart review of the patients admitted with 
DKA and placed on the updated insulin protocol included all patients admitted June 1, 2018 
through August 31, 2018.  Once adult patients with DKA were identified, the charts were 
reviewed for time frame of correction of blood glucose level, and symptoms of hypoglycemia or 
other complications post initiation of the DKA Insulin Infusion Protocol.   
Tools  
A retrospective chart review was completed on all adult patients age 18-75, admitted to 
the ICU from the ED in DKA who were placed on the initial DKA Insulin Infusion Protocol.  
The original insulin infusion protocol was examined and compared to the latest evidence-based 
practice and recommendations by the ADA.  The protocol was updated and was distributed for 
review and approval.  After approval and adoption of the updated protocol was completed, a 
second retrospective chart review was completed including patients admitted in DKA from June 
1, 2018 through August 31, 2018.  All the data collected was then placed in an Excel spreadsheet 
to graph the data using time series charts and statistically analyze the findings. In particular, 
confidence intervals for important descriptors were given and hypothesis tests were conducted to 
examine if there was statistically significant differences between the two protocols. 
Data Analysis 
Baseline data was collected at the time of inclusion in the retrospective chart review.  All 
data was then compiled and reviewed for reliability and validity to ensure inclusion criteria was 
met.  Information was collected through a review of charts for adult patients admitted with DKA 
to the ICU from the ED. The charts were reviewed to establish if the patient had any symptoms 
of hypoglycemia, were rapidly corrected and had to be given rescue medications after initiation 
of the insulin protocol.  Patient identifiers were not used as the purpose was to assess whether 
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patients rapidly corrected, have symptoms of hypoglycemia, and must be given rescue 
medications or exhibit other symptoms after initiation of the insulin infusion protocol only.  All 
data was then compiled and reviewed for reliability and validity to ensure that all inclusion or 
exclusion criteria.   
Statistical Analysis 
The pre-data showed variability in the correction of blood glucose levels.  In table 1, the 
patient had evidence which showed rapid correction.  In the hours zero to 1:55, the patient’s 
glucose level dropped from 1029 mg/dl to 551 mg/dl.  In table 2, the patient had evidence which 
showed rapid correction.  In hour 1:49 to 3:04 the patient’s blood glucose level went from 448 
mg/dl to 269 mg/dl.  In table 3, evidence exist which shows rapid correction.  A drop from 884 
mg/dl to 500 mg/dl in 2:21 hours and again from 350 mg/dl to 106 mg/dl in one hour.  This is 
well outside the recommendation of 50-70 mg/dl/hr by the American Diabetes Association 
(Wilinska & Hovorka, 2014).  In table 4, the patient went from 510 mg/dl to 430 mg/dl between 
hours 3:49 to 4:45.  The patient then had another rapid correction between 4:45 to 5:46 where the 
patient went from 430 mg/dl to 303 mg/dl.  This patient had a third episode of rapid correction 
where the patient went from 303 mg/dl to 135 mg/dl in one hour.   
In table 5, patient #14 had multiple episodes of rapid correction.  In the hours between 
zero and 1:14 the patient went from 693 mg/dl to 237 mg/dl.  Again at hours 4:30 to 5:32, the 
patient dropped from 311 mg/dl to 174 mg/dl.   
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Table 1: Pre-data patient #3 Glucose Time Series (mg/dl). 
 
Table 2: Pre-data patient #5 Glucose Time Series (mg/dl). 
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Table 3: Pre-data patient #8 Glucose Time Series. 
 
Table 4: Pre-data patient #11 Glucose Time Series (mg/dl). 
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Table 5: Pre-data patient #14 Glucose Time Series (mg/dl). 
  
Time to 
Correction 
(min) 
Time to 
Correction 
(hrs) 
High Corrected 
Value 
  Drop per 
hour 
(mg/dl/h) 
Pt1 739 12.32 544 125   34.02 
Pt3 330 5.50 1029 332   126.73 
Pt5 264 4.40 448 140   70.00 
Pt6 2761 46.02 747 81   14.47 
Pt7 3608 60.13 380 166   3.56 
Pt8 1588 26.47 884 192   26.15 
Pt11 485 8.08 616 146   58.14 
Pt12 642 10.70 297 139   14.77 
Pt13 917 15.28 377 136   15.77 
Pt14 332 5.53 693 174   93.80 
Pt15 589 9.82 572 250   32.80 
              
Mean 1114.1 18.57 598.82 171.00   44.56 
Median 642.0 10.70 572.00 146.00   32.80 
StDev 1103.6 18.39 226.31 68.33   38.60 
N 11 11 11 11   11 
Df 10           
              
Error 741.37 12.36 152.03 45.90   25.93 
Min 372.7 6.2 446.8 125.1   18.6 
Max 1855.5 30.9 750.8 216.9   70.5 
Table 6: All pre-data compiled.   
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Patient #14 Glucose Time Series (mg/dl)
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 In table 10, using the pre-protocol data there is 95% confidence that the true mean is 
correct.  The time to correction was between 6.2 and 30.9 hours.  The high glucose concentration 
during the time on the insulin infusion protocol was between 446.8 mg/dl and 750.8 mg/dl.  The 
glucose concentration at the end of the protocol or at correction is between 125.1 mg/dl and 
216.9 mg/dl. The glucose concentration reduction per hour is between 18.6 mg/dl/hr and 70.5 
mg/dl/hr.  However, this is the mean concentration reduction.  When each individual patient was 
reviewed, this was not the case as some patients were corrected at a much faster rate. 
 In the post-data, which represents the data obtained from the retrospective chart review 
after the DKA Insulin Protocol adoption, there were three episodes of rapid correction.  Table 7, 
shows that patient #4 had an episode of rapid correction between hour 7:14 and 8:06 of 220 
mg/dl to 131 mg/dl.  In table 8, the patient had an episode of rapid correction between hour 1:15 
and 2:27, of 471 mg/dl to 154 mg/dl.  And finally, in table 9, patient #7 had an overall blood 
glucose reduction from 959 mg/dl to 140 mg/dl in 6:38 hours.  This patient became symptomatic, 
and the insulin protocol had to be immediately discontinued.   
 
Table 7: Post-data patient #4 Glucose Times Series (mg/dl). 
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Table 8: Post-data patient #5 Glucose Times Series (mg/dl). 
 
Table 9: Post-data patient #7 Glucose Times Series (mg/dl). 
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Time to 
Correction 
(min) 
Time to 
Correction 
(hrs) 
High Corrected 
Value 
  Drop per 
hour 
(mg/dl/h) 
Pt #1 733 12.22 411 187   18.34 
Pt #2 778 12.97 435 145   22.37 
Pt #4 1259 20.98 579 141   20.87 
Pt #5 867 14.45 500 122   26.16 
Pt #6 487 8.12 342 171   21.07 
Pt #7 398 6.63 959 140   123.47 
              
Mean 753.67 12.56 537.67 151   38.71 
Median 755.50 12.59 467.50 143   21.72 
StDev 305.56 5.09 221.59 23.64   41.60 
N 6 6 6 6   6 
Df 5           
              
Error 320.72 5.3 232.6 24.8   43.7 
Min 432.95 7.2 305.1 126.2   -5.0 
Max 1074.38 17.9 770.3 175.8   82.4 
Table 10: Post-data compiled. 
In table 10, using the post-protocol data there is 95% confidence that the true mean is 
correct.  The time to correction was between 7.2 and 17.9 hours.  The high glucose concentration 
during the time on the insulin infusion protocol was between 305.1 mg/dl and 770.3 mg/dl.  The 
glucose concentration at the end of the protocol or at correction is between 126.2 mg/dl and 
216.9 mg/dl. The glucose concentration reduction per hour is between -5.0 mg/dl/hr and 82.4 
mg/dl/hr.  However, this is the mean concentration reduction.  When each individual patient was 
reviewed this was not the case. 
 A two-sample t-test was used on the means for the two protocols for the blood glucose 
concentration drop per hour and the time to correction.  The hypothesis test was to check if pre-
protocol change was different from the post-protocol change.  The sample sizes were npre = 11 
for the pre-protocol change group and the npost = 6 for the post-protocol.  The null hypothesis is 
the mean time to correction, for pre-protocol is equal to the post-protocol correction.  The 
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alternate hypothesis is the mean time to concentration is different between the pre-protocol and 
post-protocol correction.  The alpha= 0.05.  The t critical= 3.163381, the test stat= 360.43 and 
the standard test= 1.014261.  The standard test is not past the critical t-test (positive or negative).  
There is not enough evidence to support the claim that the mean time to correction for the two 
protocols is different.  
 The null hypothesis is that the glucose concentration drop per hour is the same for both 
the pre-protocol change and the post-protocol change.  The alternate hypothesis is that the 
glucose concentration drop per hour is different for both the pre-protocol and the post-protocol 
change.  The α = 0.05.  The t critical = 2.48988, the test statistic = 5.85 and the standardized test 
statistic = 0.290892.   
Feasibility Analysis 
This scholarly project was feasible for the organization and in fact was requested by the 
organization.  This organization saw a trend of patients with DKA who were rapidly being 
corrected, and therefore, sought to find the root cause of the problem.  Additionally, this along 
with many other policies and procedure for this organization were due for updates. 
Resources 
Outside resources were not needed in order to accomplish this scholarly project.  All of 
the staff and resources are part of the normal routine for the organization.  The only outside 
resource used was the printing company for the poster project in order to disseminate the final 
outcomes.  
Personnel 
Those involved in the process of updating the DKA Insulin Infusion Protocol include the 
Chief Nursing Officer, the Physician Informaticist, the Director of Acute Care Services, the 
SCHOLARLY PROJECT 27 
Director of Quality and Safety, the Director of Pharmacy, and the Clinical Coordinator/Educator 
Intensive Care Unit.  Additional personnel involved include the nursing education department 
and the staff for both the ICU and ED.   
Technology 
The technology which is beneficial to this scholarly project included that the organization 
has its own physician Informaticist.  He was able to quickly gather the data needed to determine 
the number of participants in the retrospective reviews.  Once this information was presented to 
the DNP student, the charts then had to be manually scrutinized to ensure they met the inclusion 
criteria.  Electronic Health Record (EHR) technology was also used.  Prior to implementation of 
the updated DKA Insulin Infusion Protocol, the nurses used paper charting to log the patients’ 
blood glucose levels and what action was taken.  After implementation of the updated protocol, a 
new feature was added to the EHR which allows the nurse to chart the time, blood glucose level, 
the rate of the insulin infusion and what action was taken.  This process has simplified the ability 
of health care providers to review the patient’s condition and outcomes.  
Significance and/or Implications 
Addressing the reason patients admitted in DKA are rapidly corrected, have 
hypoglycemic events, or other symptoms after initiation of the insulin infusion protocol benefits 
all adult patients admitted with DKA.  It is important to use evidence-based practices and the 
latest research when updating existing protocols.  Nursing practice will be enhanced through 
increased knowledge of DKA treatment and favorable patient outcomes.  
Evaluation and Dissemination 
This author used the evaluability assessment model.  This model enables the user to 
involve stakeholders in the entire process and can test assumptions and guide its adaptations to 
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real-world conditions (Brownson, Colditz, & Proctor, 2012).  Discussions were held between the 
hospital physicians, the pharmacist, hospital nurse educator and the two clinical directors 
regarding the project and the dissemination and implementation.  Another aspect of the process 
is finding the right venue to present the project (Hanrahan, Marlow, Aldrich, & Hiatt, 2012).  
Once the data was collected and analyzed concerning the project’s usefulness, the results were 
disseminated to the interdisciplinary staff.   
Dissemination of this project’s outcomes were accomplished through distribution of a 
poster presentation to colleagues.  The use of poster presentations and publications are ways to 
contribute and communicate knowledge among nurses and other healthcare professionals 
(Hanrahan, Marlow, Aldrich, & Hiatt, 2012).  According to Hanrahan, Marlow, Aldrich and 
Hiatt (2012), clinical work and evidence-based guidelines are suitable for poster presentation for 
dissemination.   
Strategies to successfully disseminate and implement this scholarly project include 
creating awareness, increasing knowledge and commitment, promoting action and adoption, 
pursing integration and sustained use (Iowa Model Collaborative, 2017).  Additionally, Moran, 
Burson and Conrad (2017), suggests the DNP disseminate their results through verbal 
presentations, podium or poster presentations, written submissions to journals and executive 
summaries submitted to the organization where the project is intended to be implemented  This 
can be accomplished in several ways and in several venues.  The poster presentation was given 
to the ICU and ED as well as becoming part of the nursing department’s staff development. 
Recommendations 
Fauquier Health is a hospital in Northern Virginia, which has experienced an increased 
number of adult patients whose blood glucose is rapidly corrected, suffer hypoglycemic events or 
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other symptoms after admission for DKA and the initiation of an insulin infusion protocol.  In 
the pre-retrospective chart review and post-retrospective chart review, only one patient was 
found to have needed rescue medications for a decreased blood glucose level that was 
symptomatic.  That patient happened to be the last patient in the second retrospective chart 
review.  However, several patients were shown to have been rapidly corrected, greater than the 
recommended 50-70 mg/dl/hr.   
The author of this scholarly project has concluded that the next course of action would be 
to examine and update the DKA protocol in the ED.  Currently the ED uses a protocol which 
includes giving insulin via intravenous push.  This practice causes the patients to be rapidly 
corrected prior to the initiation of the DKA Insulin Infusion Protocol.  Further evaluation of both 
the ED protocol and ICU protocol is needed to benefit the patients admitted with DKA to this 
facility.  
Future research is needed to increase favorable patient outcomes.  In this scholarly 
project the author reviewed the DKA Insulin Infusion Protocol only after its initiation.  It would 
be beneficial for others in the future to review how the patient is treated from the time of 
admission into the ED and until the DKA Insulin Infusion Protocol is initiated.  
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internet. 
Citation Iowa Model Collaborative. (2017). Iowa model of evidence-based practice: Revisions and validation. 
Worldviews on Evidence-Based Nursing, 14(3), 175-182. doi:10.1111/wvn.12223 
In written material, please add the following statement: 
Used/reprinted with permission from the University of Iowa Hospitals and Clinics, copyright 2015. For 
permission to use or reproduce, please contact the University of Iowa Hospitals and Clinics at 319-384-9098. 
Please contact UIHCNursingResearchandEBP@uiowa.edu or 319-384-9098 with questions. 
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Appendix D 
ICU DKA/HHS INSULIN DRIP FLOWSHEET  
Start Continuous Infusion   0.1unit/kg/hr.  
Subsequent dosing  Based on q1hr accu-check  
FSBS not <50-70mg/dl from last hr.  Re-bolus 0.14units/kg IV  
FSBS reaches 200mg/dl  Decrease rate to 0.03 units/kg/hr.  
     * For DKA, maintain this rate until FSBS of 150-200, and DKA resolved      
*For HHS, maintain this rate until FSBS of 250-300 until pt. alert and serum                
osmolar <315  
Subsequent re-bolus dosing  Re-bolus 0.14units/kg/hr. IV if glucose does not fall by 50-70mg/dl from 
pervious hour may be necessary  
  
Time/ 
Date  
Blood 
glucose  
Units/HR  
  
Pt 
wt:____kg  
  
  
FSBS >200 and 
not  
<50-70 from 
last hr.  
IV re-bolus 
required  
@0.14units/kg/hr.  
FSBS 
<200  
  
Decrease rate to  
0.03units/kg/hr. and 
maintain until  
DKA/HHS resolved  
RN signatures  
  
  
      N/A    /  
          /  
          /  
          /  
          /  
          /  
          /  
          /  
          /  
          /  
          /  
          /  
          /  
          /  
          /  
          /  
          /  
          /  
          /  
          /  
          /  
          /  
          /  
          /  
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Appendix G 
  
June 13, 2018  
  
Susan K. Lacey IRB Exemption 3365.061318: Diabetic Ketoacidosis (DKA) Insulin Infusion 
Protocol Update Using Evidence-Based Practice: A Quality Improvement Project  
  
Dear Susan K. Lacey,  
  
The Liberty University Institutional Review Board has reviewed your application in accordance 
with the Office for Human Research Protections (OHRP) and Food and Drug 
Administration (FDA) regulations and finds your study to be exempt from further IRB 
review. This means you may begin your research with the data safeguarding methods 
mentioned in your approved application, and no further IRB oversight is required.  
  
Your study falls under exemption category 46.101(b)(4), which identifies specific situations in 
which human participants research is exempt from the policy set forth in 45 CFR 
46:101(b):  
  
(4) Research involving the collection or study of existing data, documents, records, pathological 
specimens, or diagnostic specimens, if these sources are publicly available or if the 
information is recorded by the investigator in such a manner that subjects cannot be 
identified, directly or through identifiers linked to the subjects.  
  
Please note that this exemption only applies to your current research application, and any 
changes to your protocol must be reported to the Liberty IRB for verification of 
continued exemption status.  You may report these changes by submitting a change in 
protocol form or a new application to the IRB and referencing the above IRB Exemption 
number.  
  
If you have any questions about this exemption or need assistance in determining whether 
possible changes to your protocol would change your exemption status, please email us at 
irb@liberty.edu.  
  
Sincerely,   
  
G. Michele Baker, MA, CIP Administrative Chair of Institutional Research The Graduate School  
  
  
Liberty University  |  Training Champions for Christ since 1971 
